ADENOSINE-INDUCED ATRIAL ARRHYTHMIA - A PROSPECTIVE ANALYSIS
Citation
Sa. Strickberger et al., ADENOSINE-INDUCED ATRIAL ARRHYTHMIA - A PROSPECTIVE ANALYSIS, Annals of internal medicine, 127(6), 1997, pp. 417-422
Categorie Soggetti
Medicine, General & Internal
SICI code
0003-4819(1997)127:6<417:AAA-AP>2.0.ZU;2-I
Abstract
Background: Adenosine is considered safe and effective for paroxysmal
supraventricular tachycardia (PSVT), but anecdotal experience suggests
that adenosine can precipitate atrial arrhythmias. Objectives: To det
ermine the frequency and mechanisms of adenosine-induced atrial arrhyt
hmias. Setting: Clinical electrophysiology laboratory at a university
medical center.Design: Prospective observational study. Patients: 200
consecutive patients with PSVT undergoing an electrophysiology procedu
re. Intervention: During PSVT, 12 mg of adenosine was administered cen
trally through the femoral vein. Measurements: Frequency of adenosine-
induced atrial fibrillation. Results: Paroxysmal supraventricular tach
ycardia terminated after adenosine administration in 198 patients (99%
[95% CI, 96% to 100%]). Adenosine led to atrial fibrillation (n = 22)
or atrial fibrillation and atrial flutter (n = 2) in 24 patients (12%
[CI, 7.5% to 16.5%]). An atrial premature complex occurred in all 24
patients who developed atrial fibrillation, atrial flutter, or both an
d in 102 of the 176 patients (58%) who did not (P < 0.001). The mean (
+/-SD) time from the preceding atrial complex to the atrial premature
complex was shorter when an atria[ arrhythmia occurred, and the mean r
atio of this interval to the preceding atrial cycle length was also lo
wer when atrial fibrillation developed (0.37 +/- 0.16 compared with 0.
49 +/- 0.16; P = 0.002). Conclusions: The incidence of atrial fibrilla
tion induced by 12 mg of adenosine administered through the femoral ve
in was 12%. Fibrillation seems to be associated with a ''long-short''
atrial sequence. If the mechanism of PSVT is unknown and the Wolff-Par
kinson-White syndrome is possible, administration of adenosine should
be limited to medical facilities that have emergency resuscitation equ
ipment.